Bromide

Bromide

SCHEMBL596228

CCCCCCCCCCCC[Zn+].[Br-]

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.57
THRB P10828 1/20 0.57
ALDH1A1 P00352 3/20 0.47
HSD17B10 Q99714 2/20 0.47
TP53 P04637 1/20 0.47
CYP3A4 P08684 1/20 0.47
ALOX15 P16050 1/20 0.47
ALOX12 P18054 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HIF1A Q16665 1/20 0.47
DNM1 Q05193 10/20 0.45
LMNA P02545 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
SLC22A1 O15245 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL21066888 1.00 TSHR (0.57) TSHRTHRBALDH1A1HSD17B10TP53
Bromide SCHEMBL394566 1.00
Bromide SCHEMBL26105972 1.00 TSHR (0.57) TSHRTHRBALDH1A1HSD17B10TP53
Bromide SCHEMBL5512941 1.00
Bromide SCHEMBL367414 0.96
Iodide SCHEMBL395471 0.93
Iodide SCHEMBL15541312 0.93 TSHR (0.57) TSHRTHRBALDH1A1HSD17B10DNM1
Hydrochloric Acid SCHEMBL6440729 0.93 TSHR (0.57) TSHRTHRBALDH1A1HSD17B10DNM1
Iodide SCHEMBL7580905 0.93 TSHR (0.57) TSHRTHRBALDH1A1HSD17B10DNM1
Hydrochloric Acid SCHEMBL699725 0.93

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220332870-A1 Narrow Band Gap Conjugated Polymers Employing Cross-Conjugated Donors Useful In Electronic Devices THE UNIVERSITY OF SOUTHERN MISSISSIPPI (US) 2022-10-20 US disclosed
US-11359049-B2 Gold catalyzed polymerization reactions of unsaturated substrates THE UNIVERSITY OF SOUTHERN MISSISSIPPI (US) 2022-06-14 US disclosed
US-11312819-B2 Narrow band gap conjugated polymers employing cross-conjugated donors useful in electronic devices THE UNIVERSITY OF SOUTHERN MISSISSIPPI (US) 2022-04-26 US disclosed
US-20200407489-A1 Gold Catalyzed Polymerization Reactions of Unsaturated Substrates THE UNIVERSITY OF SOUTHERN MISSISSIPPI (US) 2020-12-31 US disclosed
US-10711092-B2 Gold catalyzed polymerization reactions of unsaturated substrates THE UNIVERSITY OF SOUTHERN MISSISSIPPI (US) 2020-07-14 US disclosed
EP-3504259-A2 NARROW BAND GAP CONJUGATED POLYMERS EMPLOYING CROSS-CONJUGATED DONORS USEFUL IN ELECTRONIC DEVICES Azoulay, Jason D. (US) 2019-07-03 EP disclosed
US-20190194385-A1 Narrow Band Gap Conjugated Polymers Employing Cross-Conjugated Donors Useful in Electronic Devices THE UNIVERSITY OF SOUTHERN MISSISSIPPI 2019-06-27 US disclosed
US-20190085119-A1 Gold Catalyzed Polymerization Reactions of Unsaturated Substrates THE UNIVERSITY OF SOUTHERN MISSISSIPPI 2019-03-21 US disclosed
WO-2018039347-A2 NARROW BAND GAP CONJUGATED POLYMERS EMPLOYING CROSS-CONJUGATED DONORS USEFUL IN ELECTRONIC DEVICES AZOULAY JASON D (US) 2018-03-01 WO disclosed
US-9550678-B2 Polymeric precursors for producing graphene nanoribbons and methods for preparing them BASF SE (DE) 2017-01-24 US disclosed
EP-1778695-B1 POLYMERS OF THIENO[2,3-b]THIOPHENE MERCK PATENT GMBH (DE) 2012-03-21 EP disclosed
US-8114316-B2 Monomers, oligomers and polymers of thieno[2,3-b]thiophene MERCK PATENT GMBH (DE) 2012-02-14 US disclosed
US-7714098-B2 Mono-, oligo- and polythieno[3,2-b]thiophenes MERCK PATENT GMBH (DE) 2010-05-11 US disclosed
EP-1751166-B1 MONO-, OLIGO- AND POLYTHIENO[3,2-B]THIOPHENES MERCK PATENT GMBH (DE) 2009-10-28 EP disclosed
US-20090072200-A1 MONOMERS, OLIGOMERS AND POLYMERS OF THIENO[2,3-b]THIOPHENE FLEXENABLE TECHNOLOGY LIMITED (GB) 2009-03-19 US disclosed
US-20070232812-A1 Mono-, Oligo- and Polythieno [3,2-B]Thiophenes MERCK PATENT GMBH (DE) 2007-10-04 US disclosed
EP-1778695-A1 MONOMERS, OLIGOMERS AND POLYMERS OF THIENO[2,3-b]THIOPHENE Merck Patent GmbH (DE) 2007-05-02 EP disclosed
EP-1751166-A1 MONO-, OLIGO- AND POLYTHIENO[3,2-B]THIOPHENES MERCK PATENT GmbH (DE) 2007-02-14 EP disclosed
WO-2006021277-A1 MONOMERS, OLIGOMERS AND POLYMERS OF THIENO[2,3-b]THIOPHENE MERCK PATENT GMBH (DE) 2006-03-02 WO disclosed
WO-2005111045-A1 MONO-, OLIGO- AND POLYTHIENO[3,2-b]THIOPHENES MERCK PATENT GMBH (DE) 2005-11-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232812-A1 Mono-, Oligo- and Polythieno [3,2-B]Thiophenes FHIT, FUBP3, SLCO1B3 TSHR 1273/4885THRB 649/4885ALDH1A1 3925/4885
US-20090072200-A1 MONOMERS, OLIGOMERS AND POLYMERS OF THIENO[2,3-b]THIOPHENE FHIT, NLRP3, RFT1 TSHR 580/4885THRB 836/4885ALDH1A1 3514/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.